Introduction
One of the most common lifethreatening condition affect the Egyptian population is hepatitis c virus infection [HCV] , worldwide Egypt is considered as one of the most common country affected by the virus and it had the highest prevalence of hepatitis C virus infection [1] . Angiogenesis, the formation of new blood vessels, occurs in various liver diseases such as hepatocellular carcinoma, it was also described in chronic hepatitis c virus infection [2] . Angiogenesis is a complex process that regulated by many factors, including vascular endothelial growth factor (VEGF) [3] . In the liver HSCs, Kupffer cells, regenerating hepatocytes and existing endothelial cells are responsible for the process of neo angiogenesis and production of vascular endothelial growth factor (VEGF) [4] . 
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There is no clear relation between Chronic Hepatitis C (CHC) and angiogenesis, the aim of this study is to detect the significance of vascular endothelial growth factor and its relation to hepatic neoangiogenesis in hepatitis C associated chronic liver disease.
Material and methods
Patients: A total of 70 adult patients with chronic hepatitis C infection in different stages of hepatic fibrosis, their ages ranged from 20-59 years (40.5 ± 11.4 SD), were recruited for the study. 
Results
From September 2014 to august 2016, 70 adult patients with chronic hepatitis C infection had fulfilled our inclusion criteria and were included in this study. their ages ranged from 20-59 years (40.5 ± 11.4 SD). 42 males, 28 females. All the patients had complete laboratory investigation. There was no significant relation between VEGF and laboratory parameter of the study population. 
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Discussion
Angiogenesis or the process of new vessel formation that accompanies chronic hepatitis C virus infection is integral part of tissue remodeling and provide a portal of entry for the continuing recruitment of inflammatory cells [6] . Angiogenesis had a beneficial role in the process of tissue repair and regeneration after liver necrosis [7] . Although the mechanism and pathophysiological changes that accompanies chronic hepatitis C virus infection are still unclear [8] . The present study investigated the expression of VEGF in liver tissue from patients with CHC to evaluate their role in disease progression. In this study, there is meaningful relationship between VEGF expression in liver biopsy and fibrosis stage. These results are supported by the results of the study that done by Hassan et al. who reported increased VEGF immunostaining of liver biopsy specimens from HCV infected populations. They suggested that VEGF production is stimulated by HCV infection through a mechanism including stabilization of hypoxia inducible factor-1α (HIF-1α) [9] . Also, the study done by Abe et al., [10] demonstrated that HCV core protein has the distinct potential to up regulate and sustain HIF-1α expression under hypoxia, thereby contributing to increased VEGF expression, through the HCV core/NF-kB axis). Abe et al., [10] reported that the distinct angiogenic potential of HCV core protein under hypoxia might help transformed cells survive in the hypoxic environment of the cirrhotic liver by supplying them with oxygen and nutrients. Moreover, HCV-infected hepatocytes secrete VEGF, which induces a localized depolarization of hepatocytes that promotes viral transmission between adjacent hepatocytes [11] . On the contrary side, the results of this study disagree with the study done by Mukozu, et al., [12] who found that there was no significant difference between the control group and the CHC group as regards VEGF. Also, the results of this study similar to the studies have done by of Helaly and AbouShama [13] and JanczewskaKazek et al [14] . And Sieghart et al.
[15]. Moreover, Brdoskey et al found that in the initial stages of fibrosis, the production of VEGF and the neovascularization increases; whereas in the late stages, cirrhotic nodules in hepatitis C patients are characterized by decreased density of micro vasculature and decreased VEGF production. [16] . In this study, no significant correlation between liver enzymes (AST and ALT) and VEGF P value=0.279 and 0.366 respectively. This matches with the result of the study done by Mohsen M. Maher, MD et al. who found no significant correlation between ALT and serum VEGF [17] . Mukozu et al., [12] found no significant correlation between VEGF levels and the degree of hepatic dysfunction. This could be explained by the fluctuations that occur in liver enzymes during the disease period [18] . Also, it is well known that in liver cirrhosis due to viral hepatitis serum levels of AST is usually higher than ALT with higher AST/ALT ratio [19] In the present study, no significant correlation between VEGF and platelet counts and this was similary to the study of Assy et al the study of Mohsen, et al [17, 22] suggesting that VEGF is not stored in platelets only. On the contrary Kim et al. [25] found a significant correlation between serum VEGF and platelet count in HCC patients, they didn't find a similar correlation in liver cirrhosis patients. They suggested that serum VEGF/platelet count might be used as an indicator of the development of HCC in patients with liver cirrhosis during their follow up [25] . Also, Gunsilus and Gastl, found a significant correlation between peripheral platelet count and absolute value of serum levels of VEGF in their work [26] Conclusion: Angiogenesis have a role in development of liver fibrosis and carcinogenesis in chronic HCV infection. Neovascularization was shown to be correlated with VEGF and it increased significantly with progression of liver fibrogenesis and carcinogenesis. Hence understanding the process of angiogenesis is of great help in developing new therapeutic approaches for the chronic liver disease patients.
